107 related articles for article (PubMed ID: 1827688)
1. Arginine-specific suppression of mixed lymphocyte culture reactivity by Kupffer cells--a basis of portal venous tolerance.
Callery MP; Mangino MJ; Flye MW
Transplantation; 1991 May; 51(5):1076-80. PubMed ID: 1827688
[TBL] [Abstract][Full Text] [Related]
2. Kupffer cells can present alloantigen in vitro: an effect abrogated by gadolinium.
Squiers EC; Brunson ME; Salomon DR
J Surg Res; 1993 Dec; 55(6):571-4. PubMed ID: 8246488
[TBL] [Abstract][Full Text] [Related]
3. A biologic basis for limited Kupffer cell reactivity to portal-derived endotoxin.
Callery MP; Mangino MJ; Flye MW
Surgery; 1991 Aug; 110(2):221-30. PubMed ID: 1858031
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 downregulates Kupffer cell production of IL-1 and IL-6 during hepatic regeneration.
Goss JA; Mangino MJ; Callery MP; Flye MW
Am J Physiol; 1993 Apr; 264(4 Pt 1):G601-8. PubMed ID: 8476047
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte suppression by Kupffer cells prevents portal venous tolerance induction: a study of macrophage function after intravenous gadolinium.
Roland CR; Mangino MJ; Duffy BF; Flye MW
Transplantation; 1993 May; 55(5):1151-8. PubMed ID: 8388586
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 production during hepatic regeneration downregulates Kupffer cell IL-6 production.
Goss JA; Mangino MJ; Flye MW
Ann Surg; 1992 Jun; 215(6):553-9; discussion 559-60. PubMed ID: 1632677
[TBL] [Abstract][Full Text] [Related]
7. Role of Kupffer cells in tolerance induction after portal venous administration of alloantigen.
Shimizu H; Kataoka M; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Miyazaki M
Hepatogastroenterology; 2009; 56(91-92):783-7. PubMed ID: 19621702
[TBL] [Abstract][Full Text] [Related]
8. Kupffer cell autoregulation of IL-1 production by PGE2 during hepatic regeneration.
Goss JA; Mangino MJ; Flye MW
J Surg Res; 1992 May; 52(5):422-8. PubMed ID: 1619908
[TBL] [Abstract][Full Text] [Related]
9. Portal venous transfusion up-regulates Kupffer cell cyclooxygenase activity: a mechanism of immunosuppression in organ transplantation.
Perez RV; Swanson C; Morgan M; Erickson K; Hubbard NE; German JB
Transplantation; 1997 Jul; 64(1):135-9. PubMed ID: 9233713
[TBL] [Abstract][Full Text] [Related]
10. Selective targeting of Kupffer cells with liposomal butyrate augments portal venous transfusion-induced immunosuppression.
Perez RV; Johnson J; Hubbard NE; Erickson K; Morgan M; Kim S; Rudich SM; Katznelson S; German JB
Transplantation; 1998 May; 65(10):1294-8. PubMed ID: 9625008
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 production by endotoxin-stimulated Kupffer cells is regulated by prostaglandin E2.
Callery MP; Mangino MJ; Kamei T; Flye MW
J Surg Res; 1990 Jun; 48(6):523-7. PubMed ID: 2362412
[TBL] [Abstract][Full Text] [Related]
12. In vitro analysis of gadolinium chloride abrogation of the systemic tolerance induced by portal venous administration of ultraviolet B-irradiated donor cells.
Yu S; Nakafusa Y; Flye MW
Transplantation; 1997 Dec; 64(12):1684-8. PubMed ID: 9422402
[TBL] [Abstract][Full Text] [Related]
13. Lanthanide "blockade" of antigen-presenting cells suppresses lymphocyte proliferation by inducing nitric oxide synthesis.
Roland CR; Mangino MJ; Flye MW
J Surg Res; 1993 May; 54(5):401-10. PubMed ID: 8361165
[TBL] [Abstract][Full Text] [Related]
14. Kupffer cell blockade prevents induction of portal venous tolerance in rat cardiac allograft transplantation.
Kamei T; Callery MP; Flye MW
J Surg Res; 1990 May; 48(5):393-6. PubMed ID: 2352416
[TBL] [Abstract][Full Text] [Related]
15. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance.
Yu S; Nakafusa Y; Flye MW
Surgery; 1994 Aug; 116(2):229-34; discussion 234-5. PubMed ID: 8047989
[TBL] [Abstract][Full Text] [Related]
16. Kupffer cell-mediated lymphocyte apoptosis: a PGE2-dependent mechanism of portal venous transfusion-induced immunosuppression?
Perez R; Johnson J; Winkler JD; Rudich S; Carter L; Katznelson S; German JB
J Surg Res; 1998 Jul; 78(1):37-41. PubMed ID: 9733615
[TBL] [Abstract][Full Text] [Related]
17. Sodium butyrate upregulates Kupffer cell PGE2 production and modulates immune function.
Perez R; Stevenson F; Johnson J; Morgan M; Erickson K; Hubbard NE; Morand L; Rudich S; Katznelson S; German JB
J Surg Res; 1998 Jul; 78(1):1-6. PubMed ID: 9733608
[TBL] [Abstract][Full Text] [Related]
18. Suppression of polyclonal, tumor cell and alloantigen-induced proliferation: identification of cyclooxygenase pathway dependent and independent mechanisms.
Hogan KT; Hollingsworth MA; Seymour RE; Quinn MK; Evans DL
Immunopharmacology; 1984 Feb; 7(1):49-57. PubMed ID: 6232242
[TBL] [Abstract][Full Text] [Related]
19. Autoregulation by eicosanoids of human Kupffer cell secretory products. A study of interleukin-1, interleukin-6, tumor necrosis factor-alpha, transforming growth factor-beta, and nitric oxide.
Roland CR; Goss JA; Mangino MJ; Hafenrichter D; Flye MW
Ann Surg; 1994 Apr; 219(4):389-99. PubMed ID: 8161265
[TBL] [Abstract][Full Text] [Related]
20. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine.
Hoffman RA; Langrehr JM; Billiar TR; Curran RD; Simmons RL
J Immunol; 1990 Oct; 145(7):2220-6. PubMed ID: 2144548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
